Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia

被引：0
|
作者：
Hiroyuki Hashimoto
Masato Takeuchi
Koji Kawakami
机构：
[1] Kyoto University,Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Allopurinol; Cardiovascular risk; Epidemiology; Febuxostat; Gout; Hyperuricemia; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3075 / 3082
页数：7
相关论文
共 50 条
  • [41] Adherence with urate-lowering therapy for the treatment of gout
    Harrold, Leslie R.
    Briesacher, Becky
    Raebel, Marsha
    Fouayzi, Hassan
    Yood, Robert
    Andrade, Susan
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S672 - S672
  • [42] Surprising safety outcomes of urate-lowering therapy
    McHugh, Jessica
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (06) : 320 - 320
  • [43] The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout
    Martijn Gerritsen
    Mike T. Nurmohamed
    Drugs & Aging, 2024, 41 : 319 - 328
  • [44] Cardiovascular Disease in Gout and theProtective Effect of Treatments Including Urate-Lowering Therapy
    Gupta, Manik K.
    Singh, Jasvinder A.
    DRUGS, 2019, 79 (05) : 531 - 541
  • [45] Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy
    Manik K. Gupta
    Jasvinder A. Singh
    Drugs, 2019, 79 : 531 - 541
  • [46] To Treat or Not to Treat? Effect of Urate-Lowering Therapy on Renal Function, Blood Pressure and Safety in Patients with Asymptomatic Hyperuricemia: A Systematic Review and Network Meta-Analysis
    Tien, Yu-Yu
    Shih, Ming-Chieh
    Tien, Chiao-Pang
    Huang, Huei-Kai
    Tu, Yu-Kang
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2022, 35 (01) : 140 - +
  • [47] Rapid reduction in uric acid by a urate-lowering agent is associated with recurrent cardiovascular events
    Lee, Jung Sun
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    MEDICAL HYPOTHESES, 2020, 141
  • [48] Urate Lowering Drugs for CKD Patients With Asymptomatic Hyperuricemia and Hypertension: A Randomized Trial
    Kohagura, Kentaro
    Satoh, Atsushi
    Kochi, Masako
    Kinjo, Kazushi
    Yamazato, Masanobu
    Ishida, Akio
    Sakima, Atsushi
    Iseki, Kunitoshi
    Arima, Hisatomi
    Ohya, Yusuke
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 851 - 851
  • [49] Potential Dangers of Serum Urate-Lowering Therapy
    Vanessa Perez-Gomez, Maria
    Bartsch, Lorenz-Alexander
    Castillo-Rodriguez, Esmeralda
    Fernandez-Prado, Raul
    Kanbay, Mehmet
    Ortiz, Alberto
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (04): : 457 - 467
  • [50] Urate-Lowering Therapy for Gout: Focus on Febuxostat
    Love, Bryan L.
    Barrons, Robert
    Veverka, Angie
    Snider, K. Matthew
    PHARMACOTHERAPY, 2010, 30 (06): : 594 - 608
12345